FDA Greenlights New Drug for Bipolar Depression Caplyta gained indications as monotherapy and adjunctive treatment Dec 20, 2021
It's Loud and Clear: Unwanted Noise in Medical Facilities Is a Hazard The right soundscape can benefit patients and providers alike Dec 17, 2021
DEA Chief Warns About Fake Prescription Drugs Containing Fentanyl More than 8.4 million fake pills seized since end of September Dec 17, 2021
Researchers to Study Psilocybin's Effects on Strained Healthcare Workers Psychedelic-assisted therapy to be examined on pandemic-afflicted frontline workers Dec 07, 2021
House Members Debate Cracking Down More on Fentanyl Committee criticizes Justice Department for not appearing at hearing Dec 03, 2021
Dementia Tied to Resting Heart Rate Findings persist even after accounting for cardiovascular disease Dec 03, 2021
Tracing a Killer's Path to Mass Shooting Mental health system reform is one tool in a broader playbook against gun violence Dec 03, 2021
Brain Changes Found in Fetuses of Alcohol-Using Moms Differences seen in two areas when compared with brains of non-drinking mothers Dec 01, 2021
Psychiatry and Sexism: Gender Bias in BPD Diagnosis? Why women are disproportionately diagnosed with borderline personality disorder Nov 30, 2021
Should Doctors Be Embarrassed by TV's 'Dopesick'? No, but the Hulu series holds lessons for physicians about trusting pharma messaging Nov 26, 2021
Academic Centers Start to Take Psychedelics Seriously "You're not sticking your neck out as much as you would 10 years ago," one director says Nov 24, 2021
Is Psychedelic Research Funding Starting to Shift? Once the province of philanthropy, industry and government sources show interest Nov 24, 2021
Let Ethics Guide Aducanumab Prescribing, AAN Says Don't rely on FDA approval alone to make best choices for Alzheimer's patients Nov 18, 2021
Buprenorphine Misuse: What's the Reality? New study highlights need to expand access to buprenorphine for OUD Nov 18, 2021
Jury Still Out on Lithium's Antisuicidal Effects Adjunct lithium offered no additional suicide protection for bipolar, depressed vets Nov 17, 2021
This Behavior on Digital Devices Is Linked to Worse Mental Health in Children Good news for video gamers, however Nov 17, 2021
More Data Support Antidepressant's Death Reduction in COVID-19 Best protective effects came from fluoxetine, fluvoxamine Nov 15, 2021
Aspirin Flops Again for Dementia Prevention ASCEND trial sides with ASPREE, but can't rule out some potential benefit Nov 15, 2021
Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia GIRAF trial tested warfarin versus dabigatran in older Afib patients Nov 14, 2021
Dyanavel XR OK'd in Ages 6 and Up; ADHDTok; Depression Among LGBT Native Americans News and commentary from the psychiatry world Nov 10, 2021
One Aducanumab Patient, Six Brain Edema Episodes "Uniquely complicated course" for patient treated with new Alzheimer's drug Nov 08, 2021
For Some Food-Allergic Kids (and Parents), Anaphylaxis Isn't the Worst Problem It's the unnecessary, crippling worry about the possibility of it Nov 08, 2021
FDA Panel Shows Little Love for Prader-Willi Drug Candidate All but one committee member said phase III evidence for carbetocin nasal spray was insufficient Nov 05, 2021
Prescription Pain Killers Can Be a Slippery Slope We can prevent patients from falling down the rabbit hole Nov 05, 2021
Words Matter to People Who Are Overweight New policy statement pushes "people-first" language rather than disease-first Nov 03, 2021
In Long COVID, GI and Mental Health Symptoms 'Go Hand in Hand' More severe post-COVID gastrointestinal symptoms also increased the risk for anxiety and sadness Nov 02, 2021
Improvements in Treatment-Resistant Depression With Esketamine Pooled data from randomized trials showed better scores on the PHQ-9 as well Nov 02, 2021
Lemborexant Helps Insomniacs Catch More Z's Even patients with history of depression had better sleep outcomes Nov 02, 2021
Novel Oral Antidepressant Shows Rapid Symptom Improvement Improvement with 50-mg zuranolone seen by day 3 Nov 02, 2021
Is Earlier Use of Long-Acting Injectable Drugs for Schizophrenia Better? Early use linked to fewer inpatient stays and ER visits, study finds Nov 01, 2021
Extended-Release Risperidone Injectable Staves Off Schizophrenia Relapse Phase III RISE study found benefit with both once-monthly and bimonthly dose Nov 01, 2021
COVID Doesn't Dampen LAI Antipsychotic Prescribing in Schizophrenia Survey study shows no major changes in prescription trends in 2020 Nov 01, 2021
Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety Real-world study of fremanezumab found that patients were able to reduce antidepressant use Nov 01, 2021
Antipsychotic Patch Quiets Schizophrenia-Related Hostility Most significant improvement seen with highest asenapine transdermal dose Oct 31, 2021
Michigan EDs See Jump in Cannabis-Related Neuropsychiatric Toxicity Community-based study reports "troublesome" data in state that legalized marijuana for adults Oct 30, 2021
Antidepressant for Mild COVID-19 Prevents Admissions Effect in randomized trial "compares favorably" to more pricey drugs Oct 27, 2021
Midlife Women With Declining Eyesight: Are They Also Looking at Future Depression? Varying degrees of visual impairment tied to depressive symptoms Oct 27, 2021
